Which drug eases pain better after sleeve gastrectomy?

NCT ID NCT07327905

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two drugs—lidocaine and dexmedetomidine—given as infusions during laparoscopic sleeve gastrectomy to see which one helps with pain and recovery. Forty adults aged 20-50 with a BMI of 35-50 are being recruited. The goal is to find a better way to manage early post-surgery pain and reduce complications like nausea.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lidocaine and dexmedetomidine

What this could lead to

If one drug works better, it could lead to a standard way to manage pain after weight-loss surgery, helping patients recover more comfortably.

What could go wrong

This is a small, early-stage trial with only 40 people, so results may not apply to everyone. Both drugs have side effects like nausea or low blood pressure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alexandria University

    RECRUITING

    Alexandria, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••